# How We Make Money

Canonical: https://supplementexplained.com/how-we-make-money/
Last modified: 2026-05-16T21:40:28+00:00
Indexing: noindex, follow. This markdown file is a machine-readable alternate of the canonical HTML page.
Publisher: Supplement Explained
Review model: Editorial evidence review, not medical review unless explicitly stated on the canonical page.

How We Make Money Supplement Explained earns money mainly through affiliate links and adjacent monetization methods tied to product-intent pages. If a reader uses a qualifying partner link and buys something, the site may earn a commission at no extra cost to that reader. The revenue model does not remove the obligation to publish pages that still make sense even when a reader does not click, does not buy, or decides a product is not a fit after reading the page. Revenue model Monetize where purchase intent exists The site is designed so informational pages stay useful on their own, while product pages and related buying-context pages carry the clearest commercial relationship. Disclosure Affiliate Links See how commercial links are disclosed near actions. Main monetized area Products Product pages are where the strongest purchase intent usually appears. Adjacent layer Brands Brand pages support product discovery without becoming empty sales funnels. Guardrails Editorial Policy See what the revenue model is not allowed to override. Where money is most likely to be earned The most direct monetization happens on product pages and in closely related buying-context flows. These are the areas where a reader has usually moved past broad education and is comparing specific formulas, brands, dose logic, or retailer options. Why informational pages still matter Ingredient, safety, timing, labs, quality, compare, and basics pages are not supposed to exist only as thin doorways into a retailer button. Their job is to answer the broader decision correctly, even if that leads a reader away from a product purchase or toward clinician input instead. How we try to keep incentives visible We disclose affiliate relationships near product CTAs and related product decision areas. We also use page structures that keep tradeoffs, better alternatives, skip logic, and price context visible so the page does not collapse into a sales funnel. What keeps the model credible The business model only works long-term if the site remains more useful than generic affiliate content. That means the page has to be worth reading even for someone who never buys anything. If monetization starts to weaken trust, the publishing model stops being worth protecting. Can a site make money and still be trustworthy? Yes, but only if the revenue model stays visible and the page still works without the sale. The real test is not whether a site earns money. It is whether the money quietly changes what gets said, what gets hidden, and which products keep getting pushed no matter what. What is the difference between ads, sponsorships, and affiliate links? They are different monetization routes with different pressure points. Affiliate links usually tie money to an action or sale. Ads monetize attention. Sponsorships can introduce brand relationships that need especially clear disclosure. Readers deserve to know which model is in play. What are red flags in weak monetization disclosure? Buried disclosure, vague wording, pages that feel like rankings without real tradeoffs, and product praise that never seems to cost the publisher anything are all warning signs. If the revenue model is hard to understand, trust usually gets harder too. Key Takeaways Revenue is tied mainly to affiliate actions around product-intent pages. That does not excuse weak tradeoff analysis or disguised advertorial copy. Informational pages should still stand on their own without forcing a purchase path. Trust is part of the business model, not separate from it. Next Questions to Read Affiliate Disclosure Editorial Policy Products Brands About Contact What Revenue Does Not Justify No fake review language. We do not claim hands-on testing or clinical endorsement just because a page monetizes. No tradeoff suppression. Products still need honest downside, fit, skip, and alternative sections. No hidden disclosure. Commercial context should be visible near the CTA, not buried in fine print. No thin affiliate filler. A monetized page still has to work as a real editorial decision page.